Company intelligence / Profile preview

Ionix Pharmaceuticals

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Ionix Pharmaceuticals was a biopharmaceutical company based in the United Kingdom that specialized in the discovery and development of novel therapeutics for the management of pain. The company's research focused on ion channels, particularly the Nav1.7 sodium channel and TRPV1 receptors, which play critical roles in pain signaling. Ionix utilized a proprietary drug discovery platform to identify small molecule modulators of these targets. In 2005, the company was acquired by Vernalis, which integrated Ionix's pain pipeline and expertise into its own portfolio to strengthen its position in the neurology market.

Therapeutic areas: ImmunologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Ionix Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ionix Pharmaceuticals.

Explore the full profile